96 related articles for article (PubMed ID: 19435643)
1. Long-term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer.
Bjerregaard JK; Mortensen MB; Jensen HA; Fristrup C; Svolgaard B; Schønnemann KR; Hansen TP; Nielsen M; Johansen J; Pfeiffer P
Radiother Oncol; 2009 Aug; 92(2):226-30. PubMed ID: 19435643
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
3. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial.
Pfeiffer P
Acta Oncol; 2005; 44(3):224-9. PubMed ID: 16076693
[TBL] [Abstract][Full Text] [Related]
4. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of unresectable locally advanced pancreatic cancer with combined radiotherapy and chemotherapy].
Jensen HA; Nielsen HO; Jensen JD; Fristrup CW; Nielsen M; Pfeiffer P
Ugeskr Laeger; 2008 Feb; 170(8):639-41. PubMed ID: 18364156
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T
Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative chemoradiotherapy with UFT and Leucovorin in patients with advanced rectal cancer: a phase II study.
Giralt J; Tabernero J; Navalpotro B; Capdevila J; Espin E; Casado E; Mañes A; Landolfi S; Sanchez-Garcia JL; de Torres I; Armengol M
Radiother Oncol; 2008 Dec; 89(3):263-9. PubMed ID: 18768230
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of Uracil/Tegafur plus leucovorin and celecoxib combined with radiotherapy in locally advanced pancreatic cancer.
Morak MJ; Richel DJ; van Eijck CH; Nuyttens JJ; van der Gaast A; Vervenne WL; Padmos EE; Schaake EE; Busch OR; van Tienhoven G
Radiother Oncol; 2011 Feb; 98(2):261-4. PubMed ID: 21075468
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer.
Kim HM; Bang S; Park JY; Seong J; Song SY; Chung JB; Park SW
Cancer Chemother Pharmacol; 2009 Feb; 63(3):535-41. PubMed ID: 18828020
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract.
Czito BG; Hong TJ; Cohen DP; Petros WP; Tyler DS; Pappas TN; Yu D; Lee CG; Lockhart AC; Morse MA; Fernando N; Hurwitz HI
Cancer Invest; 2006 Feb; 24(1):9-17. PubMed ID: 16466986
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram.
White RR; Kattan MW; Haney JC; Clary BM; Pappas TN; Tyler DS; Brennan MF
Ann Surg Oncol; 2006 Nov; 13(11):1485-92. PubMed ID: 17013688
[TBL] [Abstract][Full Text] [Related]
13. [5-FU based chemoradiotherapy for unresectable locally advanced pancreatic cancer].
Niki T; Soejima T; Yoshikawa T; Yamamoto Y; Fujii O; Ohta Y; Tsuda M; Horita K; Tsujino K; Hirohata S; Fujino Y; Nishisaki H
Gan To Kagaku Ryoho; 2009 Jan; 36(1):63-9. PubMed ID: 19151565
[TBL] [Abstract][Full Text] [Related]
14. [Chemoradiotherapy for locally recurrence after primary resection of biliary-pancreatic cancer].
Maemura K; Shinchi H; Noma H; Mataki Y; Kurahara H; Maeda S; Natsugoe S; Takao S
Gan To Kagaku Ryoho; 2009 Feb; 36(2):265-8. PubMed ID: 19223743
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.
Mellon EA; Hoffe SE; Springett GM; Frakes JM; Strom TJ; Hodul PJ; Malafa MP; Chuong MD; Shridhar R
Acta Oncol; 2015 Jul; 54(7):979-85. PubMed ID: 25734581
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiation therapy boost in locally advanced pancreatic cancer.
Seo Y; Kim MS; Yoo S; Cho C; Yang K; Yoo H; Choi C; Lee D; Kim J; Kim MS; Kang H; Kim Y
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1456-61. PubMed ID: 19783379
[TBL] [Abstract][Full Text] [Related]
18. Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery.
Kim MM; Mansfield PF; Das P; Janjan NA; Badgwell BD; Phan AT; Delclos ME; Maru D; Ajani JA; Crane CH; Krishnan S
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):167-72. PubMed ID: 18406886
[TBL] [Abstract][Full Text] [Related]
19. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
